slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
162,001-162,060 of 319,975
34
The slide details a SPAC transaction structure.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
35
The slide uses a series of bar charts to compare AdTheorent against a peer group (Viant, The Trade Desk, Magnite, PubMatic, Cardlytics, DoubleVerify, LiveRamp).Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
36
The slide uses two bar charts to compare valuation metrics. The '42% discount' claim is highlighted as the primary takeaway.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
37
The slide uses a grouped bar chart for growth trends and a summary table for valuation and performance metrics.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
38
Adtheorent | SPAC Presentation Deck | 45 slidesAdtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
39
Includes historical actuals (A) and projections (P).Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
40
The slide uses stacked bar charts to show year-over-year performance and growth percentages.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
41
The slide serves as a credibility-building page for the investor (H.I.G. Growth).Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
42
Uses a before-after-bridge style narrative for the case study.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
43
The slide emphasizes stability and experience through tenure metrics.Adtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
44
Adtheorent | SPAC Presentation Deck | 45 slidesAdtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
45
Adtheorent | SPAC Presentation Deck | 45 slidesAdtheorent | SPAC Presentation Deck | 45 slides · Adtheorent
Pitch deck Investment bank 1 hit
01
Advantage Solutions | Investor Presentation Deck | 9 slidesAdvantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Problem1 hit
02
The slide uses a two-column layout with a sidebar for contents and methodology.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Problem1 hit
03
Includes three distinct stacked bar charts comparing manufacturer and retailer perspectives on sales growth, online sales history, and future online sales projections.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Solution1 hit
04
The slide uses a pull-quote as a summary takeaway.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Solution1 hit
05
Data sourced from Advantage Sales survey, May 2021.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Solution1 hit
06
Contains three distinct charts summarizing survey data from Advantage Sales (May 2021).Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Solution1 hit
07
The slide uses a combination of horizontal bar charts and a stacked bar chart to compare investment focus versus perceived ROI.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · Market Size1 hit
08
Data from Advantage Sales survey, May 2021.Advantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Loop · Cost Of Inaction1 hit
09
Advantage Solutions | Investor Presentation Deck | 9 slidesAdvantage Solutions | Investor Presentation Deck | 9 slides · Advantage Solutions
Deck Investor relations Beat · The AskLoop · Cost Of Inaction1 hit
01
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
02
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
03
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
04
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Situation & Context1 hit
05
The slide uses a human body diagram to map clinical response areas.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
RP2D: Recommended Phase 2 DoseAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
07
The slide uses a table-like structure to organize clinical trial programs by name, phase, and study details.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses a process flow diagram to show how patients move from dose escalation (Part A) to expansion (Part B) and combination therapy (Part C).Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
10
Data as of March 19, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
11
Slide provides status update on clinical trial enrollment as of May 25, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
12
The chart is a swimmer plot, a common clinical trial visualization for patient-level response over time.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
13
Data cut off May 3, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
14
The chart is a swimmer plot, a common visualization in oncology clinical trials to show patient-level treatment duration and response.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
15
Data cut off May 3, 2021. PR = Partial Response.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
16
The slide details specific patient cohorts categorized by dosage and tumor type/treatment history.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
17
Data cut off May 3, 2021. Includes patient-level data for 7 patients.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
18
The chart displays individual patient responses categorized by tumor type. Stable disease is indicated by the shaded region between -30% and +20%.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
19
Data cut off May 3, 2021.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
20
The chart uses a waterfall plot format to visualize clinical trial efficacy data across multiple tumor types.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
21
Includes clinical trial abbreviations at the bottom.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Zoom In1 hit
22
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
23
The slide outlines the transition from dose-finding cohorts to a specific expansion phase.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
24
The slide uses a three-column layout to summarize clinical trial safety data.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
25
Data cut off March 19, 2021. Serum concentrations after the first dose of SC nemvaleukin.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
26
Includes both longitudinal line charts and bar charts for maximum fold change.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
27
Includes patient timeline, biomarker (CA-125) trend, target lesion size comparison, and CT scan imagery.Alkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
28
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
29
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
30
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
31
Alkermes | Results Presentation Deck | 31 slidesAlkermes | Results Presentation Deck | 31 slides · Alkermes
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
02
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
03
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
04
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
05
The slide features a high-quality photograph of an Aston Martin car against a brick wall background.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
06
The slide presents six key performance indicators: Total Retails, Total Wholesales, Revenues, Adjusted EBITDA, Free Cash Flow, and Net Debt.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Bridge1 hit
07
The slide uses a consistent color scheme where Q4 data is highlighted in a lighter green compared to Q1-Q3.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Bridge1 hit
08
Includes data on wholesale units by model, geographic wholesale change, wholesale ASP, and total retail units.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Bridge1 hit